Contestant's Case to Win
This is based on the number of votes received.
Lanzar Group is a clinical trial management and marketing company serving the pharmaceutical, biotechnology and medical device industries, specializing in the recruitment of racially and ethnically diverse patient and physician populations into clinical trials.
According to the U.S. Census Bureau, although Whites make up two thirds of the current population, minorities are expected to become the majority in 2042 and hit 54 percent by 2050. Hispanics, who make up about 16 percent of the
Population today, will account for 30 percent in 2050. Ethnic and racial minorities living in the USA are disproportionately burdened with disease morbidity and mortality. The CDC reports that death due to heart disease is more than 40% higher for African-Americans, American Indians, and Alaskan natives than that of Whites.
Hispanics are almost twice as likely to die from diabetes. Without adequate representation of these populations in clinical trials, researchers cannot learn about the potential differences among groups, nor ensure all medical treatments and therapies are reliable, valid, and generalizable across various
ages, genders, races and ethnicities.
Our mission is to serve as a center of excellence for medical research and reduce healthcare disparity by providing outstanding services in clinical trial management that results in life saving medicine for all.